Our researchers are developing new cancer immunotherapies that could help patients achieve long-term remission.
In a study published in the journal Nature Communications, researchers offers fresh insight into how the brain sets the pace of breathing.
We’re broadening the diversity of people who participate in research to improve the health of our communities.
Advances in engineering T cells to treat cancer are paving the way for new immunotherapies targeted at autoimmune diseases such as type 1 diabetes.
“What if?” Every day at Seattle Children’s Research Institute, we ask this simple two-word question.